News

Stay Updated! In The World Of Investments!
Sensex 50193.33 612.6 (1.24%)

Vivimed Labs Latest News

21

Apr, 2021

Vivimed Labs informs about compliance certificate

Vivimed Labs has informed that it has enclosed certificate received from Company's Registrar and Share Transfer Agent (RTA), Aarthi Consultants, a SEBI registered Category I RTA bearing Registration Number IN...

Read More

19

Apr, 2021

Vivimed Labs surges on getting approvals for 3 products from Hyderabad manufacturing site

Vivimed Labs is currently trading at Rs. 20.25, up by 0.50 points or 2.53% from its previous closing of Rs. 19.75 on the BSE.

The scrip opened at Rs. 20.75 and has touched...

Read More

17

Apr, 2021

Vivimed Labs gets approvals for 3 products from Hyderabad manufacturing site

Vivimed Labs has received approvals for 3 products from its state of the art manufacturing site in Hyderabad, which is PICS & Health Canada approved site. The company has received approval for Bilastine tabl...

Read More

16

Apr, 2021

Vivimed Labs informs about approval of products

Vivimed Labs has informed that it received approvals for the following 3 products from its state of the art manufacturing site in Hyderabad, which is PICS & Health Canada approved site: Bilastine tablets 20m...

Read More

08

Mar, 2021

Vivimed Labs shines on getting approval from Uzbekistan government for two products

Vivimed Labs is currently trading at Rs. 18.15, up by 0.85 points or 4.91% from its previous closing of Rs. 17.30 on the BSE.

The scrip opened at Rs. 17.40 and has touched a high an...

Read More

08

Mar, 2021

Vivimed Labs gets approval from Uzbekistan government for two products

Vivimed Labs has received approval from the Uzbekistan government for two products. The company has received approval for Bilastin tablets, which are used for the treatment of allergic Rhino conjunctivitis and Urticaria. Vivime...

Read More

22

Feb, 2021

Vivimed Labs zooms on getting approval for 1 product from Uzbekistan Government

Vivimed Labs is currently trading at Rs. 15.90, up by 1.05 points or 7.07% from its previous closing of Rs. 14.85 on the BSE.

The scrip opened at Rs. 14.85 and has touched a high an...

Read More

22

Feb, 2021

Vivimed Labs gets approval for 1 product from Uzbekistan Government

Vivimed Labs has received approval for 1 product from Uzbekistan Government for its PICS & Health Canada approved site, both facilities are situated at Hyderabad. The product is Paracetamol 125 mg/5mL + Chlorpheniramine...

Read More

02

Dec, 2020

Vivimed Labs informs about demise independent director

Vivimed Labs has informed that the sudden and sad demise of Prof. Bhagvanth Rao Mamidpalli, Independent Director of the Company, on Monday, November 30 2020. Prof.Bhagvanth Rao Mamidpalli, was appointed on the Board...

Read More

23

Nov, 2020

Vivimed Labs touches the roof on getting nod for 3 ophthalmic, 3 oral liquid suspension products

Vivimed Labs is currently trading at Rs. 17.20, up by 0.80 points or 4.88% from its previous closing of Rs. 16.40 on the BSE.

The scrip opened at Rs. 16.10 and has touched...

Read More

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback